Albany Molecular Research, Excelsyn Ltd. deal

Albany Molecular acquired chemical development and manufacturing company Excelsyn for $19 million in cash. Excelsyn reported 2009 revenues of $15 million. Albany Molecular said the deal expands its Eu...